<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Transl Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Transl Psychiatry</journal-id>
<journal-title-group>
<journal-title>Translational Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">2158-3188</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32424139</article-id>
<article-id pub-id-type="pmc">7235014</article-id>
<article-id pub-id-type="publisher-id">804</article-id>
<article-id pub-id-type="doi">10.1038/s41398-020-0804-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8491-0137</contrib-id>
<name>
<surname>Alemany-Navarro</surname>
<given-names>María</given-names>
</name>
<address>
<email>mariaalemany92@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cruz</surname>
<given-names>Raquel</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Real</surname>
<given-names>Eva</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Segalàs</surname>
<given-names>Cinto</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1468-7862</contrib-id>
<name>
<surname>Bertolín</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rabionet</surname>
<given-names>Raquel</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carracedo</surname>
<given-names>Ángel</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6231-6524</contrib-id>
<name>
<surname>Menchón</surname>
<given-names>Jose M.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alonso</surname>
<given-names>Pino</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0427 2257</institution-id><institution-id institution-id-type="GRID">grid.418284.3</institution-id><institution>Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, </institution></institution-wrap>Barcelona, Spain </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8836 0780</institution-id><institution-id institution-id-type="GRID">grid.411129.e</institution-id><institution>OCD Clinical and Research Unit, Psychiatry Department, </institution><institution>Hospital Universitari de Bellvitge, </institution></institution-wrap>Barcelona, Spain </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id><institution-id institution-id-type="GRID">grid.5841.8</institution-id><institution>Department of Clinical Sciences, Bellvitge Campus, </institution><institution>University of Barcelona, </institution></institution-wrap>Barcelona, Spain </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000109410645</institution-id><institution-id institution-id-type="GRID">grid.11794.3a</institution-id><institution>Grupo de Medicina Xenómica, CIBERER, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, </institution></institution-wrap>Santiago de Compostela, Spain </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution>CIBERSAM (Centro de Investigación en Red de Salud Mental), Instituto de Salud Carlos III, </institution></institution-wrap>Madrid, Spain </aff>
<aff id="Aff6"><label>6</label>Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id><institution-id institution-id-type="GRID">grid.5841.8</institution-id><institution>Institut de Biomedicina de la Universitat de Barcelona (IBUB), CIBERER, and Dept. Genetics, Microbiology &amp; Statistics, Faculty of Biology, University of Barcelona, </institution></institution-wrap>Barcelona, Spain </aff>
<aff id="Aff8"><label>8</label>Fundación Pública Galega de Medicina Xenómica, SERGAS, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>18</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>18</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>10</volume>
<elocation-id>151</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The multidimensional nature of obsessive-compulsive disorder (OCD) has been consistently reported. Clinical and biological characteristics have been associated with OCD dimensions in different ways. Studies suggest the existence of specific genetic bases for the different OCD dimensions. In this study, we analyze the genomic markers, genes, gene ontology and biological pathways associated with the presence of aggressive/checking, symmetry/order, contamination/cleaning, hoarding, and sexual/religious symptoms, as assessed via the Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS) in 399 probands. Logistic regression analyses were performed at the single-nucleotide polymorphism (SNP) level. Gene-based and enrichment analyses were carried out for common (SNPs) and rare variants. No SNP was associated with any dimension at a genome-wide level (<italic>p</italic> &lt; 5 × 10<sup>−8</sup>). Gene-based analyses showed one gene to be associated with hoarding (<italic>SETD3</italic>, <italic>p</italic> = 1.89 × 10<sup>−08</sup>); a gene highly expressed in the brain and which plays a role in apoptotic processes and transcriptomic changes, and another gene associated with aggressive symptoms (<italic>CPE</italic>; <italic>p</italic> = 4.42 × 10<sup>−6</sup>), which is involved in neurotrophic functions and the synthesis of peptide hormones and neurotransmitters. Different pathways or biological processes were represented by genes associated with aggressive (zinc ion response and lipid metabolism), order (lipid metabolism), sexual/religious (G protein-mediated processes) and hoarding (metabolic processes and anion transport) symptoms after FDR correction; while no pathway was associated with contamination. Specific genomic bases were found for each dimension assessed, especially in the enrichment analyses. Further research with larger samples and different techniques, such as next-generation sequencing, are needed to better understand the differential genetics of OCD dimensions.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Diagnostic markers</kwd>
<kwd>Psychiatric disorders</kwd>
<kwd>Clinical genetics</kwd>
<kwd>Clinical genetics</kwd>
<kwd>Genomics</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002809</institution-id>
<institution>Generalitat de Catalunya (Government of Catalonia)</institution>
</institution-wrap>
</funding-source>
<award-id>2017 FI_B 00327</award-id>
<principal-award-recipient>
<name>
<surname>Alemany-Navarro</surname>
<given-names>María</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004895</institution-id>
<institution>EC | Directorate-General for Employment, Social Affairs and Inclusion | European Social Fund (Fondo Social Europeo)</institution>
</institution-wrap>
</funding-source>
<award-id>2017 FI_B 00327</award-id>
<principal-award-recipient>
<name>
<surname>Alemany-Navarro</surname>
<given-names>María</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004587</institution-id>
<institution>Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)</institution>
</institution-wrap>
</funding-source>
<award-id>PI18/00856</award-id>
<principal-award-recipient>
<name>
<surname>Alonso</surname>
<given-names>Pino</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par2">Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition that has an estimated prevalence of 2–3%<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Despite the unitary nosological status of OCD (DSM-5), considerable heterogeneity of OCD symptoms exists. Several studies have looked into different symptom dimensions present in OCD; some have reported exploratory or confirmatory factor analysis based on Yale-Brown Obsessive Compulsive Scale Checklist (Y-BOCS-CL) items. Most of those studies have reported four or five main (second-order) factors, which in part depend on the methodology employed<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>, thereby suggesting a multidimensional model for OCD. This multidimensional nature of OCD has been confirmed by meta-analyses and systematic reviews<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. Along these lines, specific instruments such as the Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>;) have been developed to assess OCD severity in different symptom dimensions.</p>
<p id="Par3">A range of clinical characteristics has been associated with OCD symptom dimensions in different ways. In this vein, it has been proposed that the hoarding and symmetry dimensions are characteristic of an early-age OCD group<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. In terms of comorbidities, a factor comprising aggressive, sexual and religious symptoms has been associated with comorbid major depressive disorder and bipolar disorder (MDD/BD); while patients with symmetry/order symptoms show greater comorbidity with eating and addictive disorders as well as attention-deficit/hyperactivity disorder (ADHD)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Meanwhile, the contamination/cleaning dimension has been reported as the dimension that is least frequently associated with any other Axis I disorder<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. In addition, the hoarding and symmetry/order dimensions have been associated with a poorer response to pharmacological treatment<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
<p id="Par4">Differential endophenotypic profiles have also been reported in relation to symptom dimensions in neuroimaging studies. For instance, OCD probands with symmetry/order symptoms have been reported to present a reduced volume of the right precentral gyrus<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> and the hippocampus, which is also associated with aggressive/checking symptoms when compared to healthy controls<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. In addition, the aggressive/checking and contamination/cleaning dimensions have been negatively correlated to right cerebellum and right insula volumes, respectively<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. In terms of functionality, patients with aggressive/checking and sexual/religious symptoms have been found to present greater amygdala activation when confronted by fear-inducing stimuli<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Also, differences in connectivity have been observed between the aggressive/checking, sexual/religious and hoarding dimensions<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. Although we do not know to what extent these observed neurological differences between the OCD dimensions have a genetic basis, some of the structural and functional brain characteristics identified have been directly related to certain genetic variants in OCD patients as well as in those with other psychiatric disorders<sup><xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR20">20</xref></sup>.</p>
<p id="Par5">In fact, specific genetic bases have been identified for the different OCD symptom dimensions. For instance, severity of the contamination/cleaning dimension has been associated with both the Met allele of the Vall66Met locus within the brain-derived neurotrophic factor gene (<italic>BDNF</italic>)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> and the c.256G allele of the 5-hydroxytryptamine receptor 3E (<italic>HTR3E</italic>) variant rs7627615<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. The presence of this dimension has also been associated with the variants rs4657411 within the LIM homeobox transcription factor 1 alpha gene (<italic>LMX1A</italic>), and rs2075507 of the catechol-<italic>O</italic>-methyltranspherase gene (<italic>COMT</italic>) in women<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. In addition, a protective role against these dimensions has been attributed to the ACCCG haplotype of the estrogen receptor 1 gene (<italic>ESR1</italic>)<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. The symmetry/order dimension has been related to the S allele and the SS genotype of the serotonin transporter polymorphic region (SERTPR)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>; the presence of the 2R allele within the dopamine receptor D4 gene (<italic>DRD4</italic>) 48-bp variable number of tandem repeats polymorphism (VNTR)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>; and the A allele in the <italic>COMT</italic> variant rs2075507 in men<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. This dimension in combination with aggressive/checking behavior has been associated with specific variants in a promoter region of the glutamate ionotropic receptor NMDA-type subunit 2B gene (<italic>GRIN2B</italic>) (rs1019385)<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> and the SLIT and NTRK-like family member 1 gene (<italic>SLITRK1)</italic> (rs9593835); the latter, specifically in men<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. The SERTPR has also been associated with higher scores in a religious/somatic dimension (l/s and l/l genotypes)<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> and in counting and repeating rituals in OCD patients with a comorbid tic disorder (l/l genotype)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Women who exhibit hoarding symptoms have been reported to present a higher frequency of the Met/Met genotype of the <italic>COMT</italic> variant rs4680 than those who do not. Hoarding has also been associated with a variant (rs1017412) within the neurotrophic receptor tyrosine kinase 3 gene (<italic>NTRK</italic>)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> and with both the short variant of the serotonin-transporter-linked polymorphic region (5HTTLPR), and its long variant together with the G allele at rs25531 in males<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. A neutralization dimension, as assessed by the Obsessive-Compulsive Inventory-Revised (OCI-R) has been associated with a variant of <italic>LMX1A</italic> (rs4657411)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Severity scores in a dimension comprising somatic and sensory phenomena symptoms have shown a trend towards an association with the Val58Met genotype of the <italic>COMT</italic> gene in interaction with sex, with women presenting lower scores<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p>
<p id="Par6">Although a large number of studies have focused on elucidating the genetic basis of OCD, inconsistent results have been reported in most respects<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. A possible explanation for this is that the studies do not usually consider different symptom profiles among OCD patients. It has consistently been argued that it is necessary to account for OCD heterogeneity in genetic and neurobiological studies<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Therefore, in this study, we analyze the variants, genes and functional pathways that might be differentially involved in the OCD dimensions measured by the DY-BOCS<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> through an exploratory genomic method. We hypothesize that different genomic bases will be found for the different OCD dimensions.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Subjects</title>
<p id="Par7">Three hundred and ninety-nine Caucasian Spanish patients (<italic>n</italic> = 399; 210 women; mean age = 35 ± 11) with an OCD diagnosis were recruited from the OCD clinic at Bellvitge Hospital (Barcelona, Spain). Diagnoses were made by three psychiatrists with extensive clinical experience in OCD, following the DSM-IV criteria for OCD diagnosis<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> using the Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCIDCV)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. All the patients had the disorder for at least one year. Those patients presenting psychoactive substance abuse/dependence (current or in the past six months), psychotic disorders, intellectual disability, severe organic or neurological pathology (except tic disorders), or autism spectrum disorders were excluded from the study. Other affective and anxiety disorders were not criteria for exclusion in cases where OCD was the main diagnosis.</p>
<p id="Par8">Participants were required to give written consent after being fully informed about the study. The study was approved by the Ethical Committees of Bellvitge Hospital and was performed in accordance with the Helsinki Declaration of the World Medical Association.</p>
</sec>
<sec id="Sec4">
<title>Clinical assessment</title>
<p id="Par9">Medical data and both sociodemographic and clinical characteristics were collected via a structured interview during each patient’s first appointment at the clinic.</p>
<p id="Par10">Age at onset was defined as the moment when obsessive symptoms reached a clinically significant level. Family psychiatric history was considered dichotomously, but specific information regarding family history of OCD, Tourette syndrome and depression was also collected. Only family members who had received a formal diagnosis were considered to be affected.</p>
<p id="Par11">Baseline severity of obsessive and compulsive symptoms was also assessed through the clinician-administered version of the Y-BOCS<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> during the patient’s first visit to the clinic. A global measure, as well as independent measures for both obsessions and compulsions, were recorded.</p>
<sec id="Sec5">
<title>OCD Dimension: presence and severity</title>
<p id="Par12">Dimension-specific presence and severity were evaluated using the DY-BOCS<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, which is composed of a self-report part and a clinician-rated instrument. It assesses OCD severity in six different symptom dimensions that gather together thematically similar symptoms. The six are: aggressive obsessions and checking compulsions (aggressive/checking); symmetry obsessions and order compulsions (symmetry/order); contamination obsessions and cleaning/washing compulsions (contamination/cleaning); hoarding obsessions and compulsions (hoarding); sexual or religious obsessions accompanied by different rituals (sexual/religious); and a miscellaneous dimension including other obsessive thoughts and compulsive behavior (miscellaneous). We did not consider this last dimension in our analyses given its lack of specificity.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Genotyping data and quality control</title>
<p id="Par13">Our sample consisted of 399 OCD patients genotyped using the Infinium PsychArray-24 BeadChip from Illumina. This array was developed in collaboration with the Psychiatric Genomics Consortium (PGC) and includes 50,000 variants associated with common psychiatric disorders. Variant calling was performed using three different algorithms: GenCall, which is Illumina’s default calling algorithm, and Birdseed, both for common variants; and zCall, aimed at rare variant calling. A unique set of genotypes was derived from a consensus merge of the GenCall and Birdseed common variants, also including rare variants called by zCall that passed quality control (QC) from the consensus merge of GenCall and Birdseed.</p>
<p id="Par14">QC filtering of genotype data was performed using PLINK<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Only non-monomorphic autosomal biallelic variants in Hardy Weinberg equilibrium (<italic>p</italic> &lt; 0.0001) with a call rate of above 98% were included.</p>
<p id="Par15">Samples that had a call rate lower than 98% were removed. Identity by descent was calculated using independent SNPs, and omitting those samples with a pi-hat greater than 0.2<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Population stratification was tested by principal component analysis, removing those samples that deviated by more than 5 standard deviations (SDs) from the mean in the first two components.</p>
</sec>
<sec id="Sec7">
<title>Statistical analysis</title>
<p id="Par16">Association analyses at the SNP level were performed using the GenABEL library for R software<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Regression analyses were carried out under a log-additive model (in which the genotypes were coded as 0, 1 or 2 depending on the number of minor alleles). These operations were performed for autosomal SNPs (markers showing a minor allele frequency (MAF) &gt; 0.05 in autosomes). Given the non-normality of the DY-BOCS scores and the impossibility of normalizing them, these variables were dichotomized to analyze the presence/absence of the different DY-BOCS dimensions. A logistic regression analysis was performed for each dimension, with the dependent variable being the dimension we were testing. Age, sex, and the four other dimensions were included as covariates in all the models. Linkage-disequilibrium (LD) plots were designed using the LocusZoom software, based on 1000 genome CEU population data (hg19/1000 Genomes Mar 2012 EUR)<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. For SNP annotation, we used the Infinium PsychArray Gene Annotation File provided by Illumina (<ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/downloads/infinium-psycharray-product-support-files.html">https://support.illumina.com/downloads/infinium-psycharray-product-support-files.html</ext-link>).</p>
<p id="Par17">Power calculations were performed with Genetic Association Study Power Calculator software (<ext-link ext-link-type="uri" xlink:href="http://csg.sph.umich.edu/abecasis/cats/gas_power_calculator/reference.html">http://csg.sph.umich.edu/abecasis/cats/gas_power_calculator/reference.html</ext-link>) to determine the power of our study to detect associations considering our sample size.</p>
<p id="Par18">Gene-based association analyses were performed via the Sequence Kernel Association Test (SKAT)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> using the SKATMeta library<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> for R software. This type of gene-based analysis has the advantage of including rare variants, which were not considered in SNP-based analyses given the lack of statistical power for detecting associations with these variants at a single-variant level. SKAT combines the effects of common and rare variants in gene-sets, increasing the power to detect small effects.</p>
<p id="Par19">Only results from genes with at least two genotyped markers were considered. A false discovery rate (FDR) correction was used as a significance criterion.</p>
<p id="Par20">Finally, enrichment analyses were performed for genes with at least two genotyped markers that had a SKAT <italic>p</italic>-value lower than 0.01 using web-accessible DAVID (Database for Annotation, Visualization, and Integrated Discovery) Bioinformatic Resources v6.8<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. This software analyzes input genes in the context of a genomic background (in this study, we selected the entire human genome as background) to cluster genes enriched in biological pathways and gene ontologies. We ordered the reported results by the FDR statistic to prioritize for further interpretation.</p>
</sec>
</sec>
<sec id="Sec8" sec-type="results">
<title>Results</title>
<sec id="Sec9">
<title>Subjects and genotyping quality control</title>
<p id="Par21">Three hundred and seventy-six (<italic>n</italic> = 376) samples passed quality control procedures. Table <xref ref-type="table" rid="Tab1">1</xref> summarizes the sociodemographic and clinical data including DY-BOCS scores gathered for the final OCD sample.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Sociodemographic and clinical characteristics of the sample of 376 OCD patients.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Age, years</td><td>35.2 ± 10.7 (18–71)</td></tr><tr><td>Male/Female</td><td>186/190 (49.5/ 50.5)</td></tr><tr><td>Age at onset of OCD</td><td>19.9 ± 8.9 (4–46)<sup>a</sup></td></tr><tr><td colspan="2"><italic>Y-BOCS score</italic></td></tr><tr><td> Global</td><td>25.8 ± 5.5 (9–40)</td></tr><tr><td> Obsessions</td><td>12.6 ± 3.6 (0–20)</td></tr><tr><td> Compulsions</td><td>12.3 ± 4.0 (0–20)</td></tr><tr><td><italic>Baseline HDRS score</italic></td><td>12.2 ± 6.0 (0–29)</td></tr><tr><td colspan="2"><italic>Current comorbidity</italic></td></tr><tr><td> No comorbidity</td><td>212 (56.4)</td></tr><tr><td> Mood disorder</td><td>71 (18.9)</td></tr><tr><td> Tics</td><td>52 (13.8)</td></tr><tr><td> Eating disorders</td><td>19 (05.1)</td></tr><tr><td colspan="2"><italic>Presence of dimensions in worst-ever period</italic></td></tr><tr><td> Aggresive/checking</td><td>278 (73.9)</td></tr><tr><td> Symmetry/ordering</td><td>162 (43.1)</td></tr><tr><td> Contamination/cleaning</td><td>172 (45.7)</td></tr><tr><td> Hoarding</td><td>91 (24.2)</td></tr><tr><td> Sexual/religious</td><td>95 (25.3)</td></tr><tr><td colspan="2"><italic>Family psychiatric history</italic></td></tr><tr><td> No psychiatric diagnosis</td><td>138 (36.7)</td></tr><tr><td> OCD</td><td>81 (21.5)</td></tr><tr><td> Mood disorder</td><td>114 (30.3)</td></tr><tr><td> Tics/ Tourette sydrome</td><td>35 (9.3)</td></tr></tbody></table><table-wrap-foot><p>Data are mean ± SD (range) or percentage (%).</p><p><italic>OCD</italic> obsessive compulsive disorder, <italic>Y-BOCS</italic> Yale-Brown Obsessive Compulsive Scale, <italic>HDRS</italic> Hamilton Depression Rating Scale.</p><p><sup>a</sup>Age at onset was collected for 374 patients (<italic>n</italic> = 374).</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec10">
<title>SNP-level association analyses</title>
<p id="Par22">Our total dataset consisted of 338,357 autosomal markers, of which 258,937 were SNPs (MAF ≥ 0.05).</p>
<p id="Par23">No SNP exceeded the statistical threshold for genome-wide significance (<italic>p</italic> &lt; 5 × 10<sup>−8</sup>) in any dimension (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). The results at a <italic>p</italic> value ≤ 10<sup>−4</sup> for the five dimensions can be seen in Table <xref ref-type="table" rid="Tab2">2</xref>. Suggestive associations (<italic>p</italic> &lt; 10<sup>−5</sup>) were found with the aggressive, contamination, order, and hoarding dimensions (Fig. <xref ref-type="fig" rid="Fig1">1a–d</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Manhattan plots for the genome-wide association analyses of genetic variations and OCD dimensions.</title><p><bold>a</bold> Aggressive dimension. <bold>b</bold> Contamination dimension. <bold>c</bold> Order dimension. <bold>d</bold> Hoarding dimension. <bold>e</bold> Sexual/religious dimension. A blue line indicates the level of suggestive evidence of association (<italic>p</italic> &lt; 1 × 10<sup>−5</sup>).</p></caption><graphic id="d29e973" xlink:href="41398_2020_804_Fig1_HTML"></graphic></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Results from SNP_level regression analyses on OCD dimensions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP</th><th>N Cases (MAF)</th><th>N Controls (MAF)</th><th>OR (CI)</th><th><italic>P</italic></th><th>CHR</th><th>Position (BP)</th><th>A1/A2</th><th>Gene</th><th>Upstream gene</th><th>Downstream gene</th></tr></thead><tbody><tr><td colspan="11"><italic>Aggressive dimension</italic></td></tr><tr><td> rs11127905</td><td>277 (0.28)</td><td>97 (0.14)</td><td>2.55 (2.01–3.25)</td><td>9.89 × 10<sup>−05</sup></td><td>chr3</td><td>85710336</td><td>[T/C]</td><td><italic>CADM2</italic></td><td></td><td></td></tr><tr><td> rs1202392</td><td>278 (0.13)</td><td>97 (0.25)</td><td>0.42 (0.34–0.52)</td><td>7.91 × 10<sup>−05</sup></td><td>chr7</td><td>148914740</td><td>[A/G]</td><td><italic>ZNF282</italic></td><td></td><td></td></tr><tr><td> rs13064299</td><td>278 (0.43)</td><td>97 (0.63)</td><td>0.45 (0.37–0.54)</td><td>8.66 × 10<sup>−06</sup></td><td>chr3</td><td>187865100</td><td>[T/C]</td><td></td><td><italic>RP11-430L16.1</italic> (292)</td><td><italic>LPP-AS2</italic> (3894)</td></tr><tr><td> rs13180857</td><td>278 (0.37)</td><td>97 (0.54)</td><td>0.45 (0.37–0.54)</td><td>2.31 × 10<sup>−05</sup></td><td>chr5</td><td>124754302</td><td>[T/C]</td><td></td><td><italic>RP11-395P13.6</italic> (22629)</td><td><italic>RP11-756H20.1</italic> (74652)</td></tr><tr><td> rs16918167</td><td>278 (0.27)</td><td>97 (0.43)</td><td>0.49 (0.41–0.59)</td><td>7.96 × 10<sup>−05</sup></td><td>chr9</td><td>101815339</td><td>[T/G]</td><td><italic>COL15A1</italic></td><td></td><td></td></tr><tr><td> rs2189993</td><td>278 (0.54)</td><td>97 (0.38)</td><td>2.13 (1.76–2.57)</td><td>7.10 × 10<sup>−05</sup></td><td>chr7</td><td>82193853</td><td>[A/G]</td><td></td><td><italic>CACNA2D1</italic> (120739)</td><td><italic>MTHFD2P5</italic> (25311)</td></tr><tr><td> rs3799867</td><td>278 (0.14)</td><td>97 (0.27)</td><td>0.42 (0.33–0.52)</td><td>5.62 × 10<sup>−05</sup></td><td>chr6</td><td>46594121</td><td>[A/G]</td><td><italic>CYP39A1</italic></td><td></td><td></td></tr><tr><td> rs41307</td><td>278 (0.45)</td><td>97 (0.62)</td><td>0.47 (0.39–0.57)</td><td>4.95 × 10<sup>−05</sup></td><td>chr7</td><td>28674854</td><td>[T/C]</td><td><italic>CRX10B5</italic></td><td></td><td></td></tr><tr><td> rs6819000</td><td>278 (0.34)</td><td>97 (0.50)</td><td>0.48 (0.40–0.57)</td><td>6.46 × 10<sup>−05</sup></td><td>chr4</td><td>65574910</td><td>[T/G]</td><td></td><td><italic>RP11-63H19.6</italic> (97304)</td><td><italic>RP11-158O16.1</italic> (57938)</td></tr><tr><td> rs9463221</td><td>278 (0.14)</td><td>97 (0.27)</td><td>0.42 (0.34–0.52)</td><td>7.22 × 10<sup>−05</sup></td><td>chr6</td><td>46588027</td><td>[T/G]</td><td><italic>CYP39A1</italic></td><td></td><td></td></tr><tr><td colspan="11"><italic>Contamination dimension</italic></td></tr><tr><td> rs10466538</td><td>172 (0.18)</td><td>203 (0.08)</td><td>2.71 (2.13–3.46)</td><td>3.95 × 10<sup>−05</sup></td><td>chr11</td><td>125169468</td><td>[T/G]</td><td><italic>PKNOX2</italic></td><td></td><td></td></tr><tr><td> rs10882846</td><td>172 (0.15)</td><td>203 (0.26)</td><td>0.45 (0.37–0.55)</td><td>9.18 × 10<sup>−05</sup></td><td>chr10</td><td>82984432</td><td>[T/C]</td><td></td><td><italic>AL356154.1</italic> (79945)</td><td><italic>NRG3</italic> (650638)</td></tr><tr><td> rs11016302</td><td>172 (0.20)</td><td>203 (0.09)</td><td>2.35 (1.89–2.92)</td><td>8.99 × 10<sup>−05</sup></td><td>chr10</td><td>130320996</td><td>[A/C]</td><td></td><td><italic>RP11–264X1018.1</italic> (202518)</td><td><italic>RP11-442O18.2</italic> (390147)</td></tr><tr><td> rs11158195</td><td>172 (0.41)</td><td>203 (0.55)</td><td>0.54 (0.46–0.63)</td><td>8.80 × 10<sup>−05</sup></td><td>chr14</td><td>58507598</td><td>[A/G]</td><td><italic>C14orf37</italic></td><td></td><td></td></tr><tr><td> rs11210992</td><td>171 (0.37)</td><td>203 (0.52)</td><td>0.54 (0.46–0.63)</td><td>6.74 × 10<sup>−05</sup></td><td>chr1</td><td>44878549</td><td>[T/C]</td><td><italic>RNF220</italic></td><td></td><td></td></tr><tr><td> rs12832515</td><td>172 (0.32)</td><td>203 (0.19)</td><td>2.19 (1.82–2.63)</td><td>2.15 × 10<sup>−05</sup></td><td>chr12</td><td>128219762</td><td>[A/G]</td><td></td><td><italic>RP11-526P6.1</italic> (98750)</td><td><italic>RP11-749H20.1</italic> (58310)</td></tr><tr><td> rs1557627</td><td>170 (0.32)</td><td>203 (0.18)</td><td>2.34 (1.94–2.83)</td><td>6.96 × 10<sup>−06</sup></td><td>chr22</td><td>19677207</td><td>[T/C]</td><td></td><td><italic>AC000067.1</italic> (22129)</td><td><italic>sx10p-05</italic> (24780)</td></tr><tr><td> rs16935065</td><td>172 (0.22)</td><td>203 (0.11)</td><td>2.32 (1.88–2.86)</td><td>5.96 × 10<sup>−05</sup></td><td>chr8</td><td>69699756</td><td>[A/G]</td><td><italic>C8orf34</italic></td><td></td><td></td></tr><tr><td> rs2492501</td><td>172 (0.28)</td><td>203 (0.16)</td><td>2.10 (1.75–2.52)</td><td>4.98 × 10<sup>−05</sup></td><td>chr1</td><td>112931256</td><td>[T/G]</td><td></td><td><italic>snoU13</italic> (17527)</td><td><italic>CTTNBP2NL</italic> (7547)</td></tr><tr><td> rs515077</td><td>172 (0.44)</td><td>203 (0.29)</td><td>2.07 (1.76–2.44)</td><td>9.00;× 10<sup>−06</sup></td><td>chr6</td><td>8180286</td><td>[A/G]</td><td></td><td><italic>EEF1E1</italic> (77475)</td><td><italic>RP11–203H2.1</italic> (149602)</td></tr><tr><td> rs6477714</td><td>172 (0.30)</td><td>203 (0.45)</td><td>0.51 (0.44–0.60)</td><td>3.04 × 10<sup>−05</sup></td><td>chr9</td><td>112367400</td><td>[T/G]</td><td></td><td><italic>YBX1P6</italic> (70788)</td><td><italic>PALM2</italic> (35668)</td></tr><tr><td> rs7671165</td><td>172 (0.20)</td><td>203 (0.33)</td><td>0.46 (0.39–0.56)</td><td>3.39 × 10<sup>−05</sup></td><td>chr4</td><td>6401102</td><td>[T/C]</td><td><italic>PPP2R2C</italic></td><td></td><td></td></tr><tr><td> rs78287729</td><td>172 (0.10)</td><td>203 (0.03)</td><td>4.35 (3.04–6.24)</td><td>4.53 × 10<sup>−05</sup></td><td>chr4</td><td>145192851</td><td>[T/G]</td><td></td><td><italic>GYPA</italic> (130947)</td><td><italic>RP11-361D14.2</italic> (234201)</td></tr><tr><td> rs7925725</td><td>172 (0.33)</td><td>203 (0.48)</td><td>0.51 (0.43–0.60)</td><td>4.24 × 10<sup>−05</sup></td><td>chr11</td><td>131449365</td><td>[A/C]</td><td><italic>NTM</italic></td><td></td><td></td></tr><tr><td> rs7968104</td><td>172 (0.31)</td><td>203 (0.18)</td><td>2.16 (1.80–2.60)</td><td>2.97 × 10<sup>−05</sup></td><td>chr12</td><td>128222410</td><td>[A/G]</td><td></td><td><italic>RP11-526P6.1</italic> (101398)</td><td><italic>RP11-749H20.1</italic> (55662)</td></tr><tr><td> rs8123755</td><td>172 (0.07)</td><td>203 (0.17)</td><td>0.34 (0.26–0.44)</td><td>4.63 × 10<sup>−05</sup></td><td>chr20</td><td>23682133</td><td>[A/G]</td><td></td><td><italic>CST4</italic> (12456)</td><td><italic>CST2P1</italic> (9824)</td></tr><tr><td> rs930134</td><td>172 (0.57)</td><td>203 (0.42)</td><td>1.95 (1.67–2.29)</td><td>2.41 × 10<sup>−05</sup></td><td>chr18</td><td>71568010</td><td>[A/G]</td><td></td><td><italic>RN7SL401P</italic> (155546)</td><td><italic>RP11-25L3.3</italic> (13630)</td></tr><tr><td> rs9546461</td><td>172 (0.57)</td><td>203 (0.42)</td><td>1.85 (1.58–2.16)</td><td>8.42 × 10<sup>−05</sup></td><td>chr13</td><td>84212815</td><td>[T/C]</td><td></td><td><italic>RNU6-67P</italic> (340513)</td><td><italic>SLITRK1</italic> (238529)</td></tr><tr><td> rs985035</td><td>172 (0.57)</td><td>203 (0.41)</td><td>1.93 (1.65–2.25)</td><td>2.37 × 10<sup>−05</sup></td><td>chr13</td><td>84262897</td><td>[A/G]</td><td></td><td><italic>RNU6-67P</italic> (390595)</td><td><italic>SLITRK1</italic> (188447)</td></tr><tr><td colspan="11"><italic>Order dimension</italic></td></tr><tr><td> rs1039038</td><td>172 (0.46)</td><td>203 (0.51)</td><td>0.48 (0.41–0.57)</td><td>5.54 × 10<sup>−06</sup></td><td>chr11</td><td>40511611</td><td>[A/C]</td><td><italic>LRRC4C</italic></td><td></td><td></td></tr><tr><td> rs10771752</td><td>172 (0.49)</td><td>202 (0.47)</td><td>2.21 (1.87–2.61)</td><td>1.83 × 10<sup>−06</sup></td><td>chr12</td><td>30802885</td><td>[A/C]</td><td><italic>IPO8</italic></td><td></td><td></td></tr><tr><td> rs10979978</td><td>172 (0.25)</td><td>203 (0.34)</td><td>0.49 (0.41–0.59)</td><td>7.79 × 10<sup>−05</sup></td><td>chr9</td><td>112406744</td><td>[T/C]</td><td><italic>PALM2</italic></td><td></td><td></td></tr><tr><td> rs12146709</td><td>172 (0.23)</td><td>203 (0.20)</td><td>2.50 (2.05–3.05)</td><td>3.70 × 10<sup>−06</sup></td><td>chr12</td><td>30888001</td><td>[T/C]</td><td><italic>CAPRIN2</italic></td><td></td><td></td></tr><tr><td> rs12294573</td><td>172 (0.35)</td><td>203 (0.36)</td><td>1.97 (1.67–2.33)</td><td>4.75 × 10<sup>−05</sup></td><td>chr11</td><td>24087714</td><td>[T/C]</td><td></td><td><italic>RNU6-783P</italic> (216286)</td><td><italic>RP11-2F20.1</italic> (169309)</td></tr><tr><td> rs14139</td><td>172 (0.50)</td><td>203 (0.47)</td><td>2.22 (1.88–2.63)</td><td>1.50 × 10<sup>−06</sup></td><td>chr12</td><td>30782598</td><td>[T/C]</td><td><italic>IPO8</italic></td><td></td><td></td></tr><tr><td> rs1601548</td><td>172 (0.39)</td><td>203 (0.38)</td><td>0.50 (0.42–0.59)</td><td>6.30 × 10<sup>−05</sup></td><td>chr2</td><td>108735612</td><td>[T/C]</td><td></td><td><italic>AC023672.1</italic> (19664)</td><td><italic>AC019100.3</italic> (48592)</td></tr><tr><td> rs16888991</td><td>172 (0.29)</td><td>203 (0.30)</td><td>2.02 (1.70–2.40)</td><td>4.35 × 10<sup>−05</sup></td><td>chr5</td><td>21168358</td><td>[T/C]</td><td></td><td><italic>RP11-774D14.1</italic> (230558)</td><td><italic>RP11-811J10.1</italic> (28471)</td></tr><tr><td> rs1811248</td><td>172 (0.33)</td><td>203 (0.38)</td><td>0.52 (0.44–0.61)</td><td>8.40 × 10<sup>−05</sup></td><td>chr7</td><td>28421036</td><td>[T/G]</td><td><italic>CRX10B5</italic></td><td></td><td></td></tr><tr><td> rs2249654</td><td>172 (0.19)</td><td>203 (0.18)</td><td>0.36 (0.29–0.46)</td><td>8.04 × 10<sup>−06</sup></td><td>chr5</td><td>53892279</td><td>[A/G]</td><td></td><td><italic>SNX18</italic> (49864)</td><td><italic>AC112198.1</italic> (211759)</td></tr><tr><td> rs2724693</td><td>172 (0.29)</td><td>203 (0.27)</td><td>2.02 (1.71–2.39)</td><td>2.47 × 10<sup>−05</sup></td><td>chr3</td><td>137807259</td><td>[A/G]</td><td><italic>DZIP1L</italic></td><td></td><td></td></tr><tr><td> rs2724693</td><td>172 (0.29)</td><td>203 (0.27)</td><td>2.02 (1.71–2.39)</td><td>2.47 × 10<sup>−05</sup></td><td>chr3</td><td>137807259</td><td>[A/G]</td><td><italic>DZIP1L</italic></td><td></td><td></td></tr><tr><td> rs2724697</td><td>172 (0.29)</td><td>203 (0.27)</td><td>1.98 (1.68–2.34)</td><td>3.82 × 10<sup>−05</sup></td><td>chr3</td><td>137798155</td><td>[T/C]</td><td><italic>DZIP1L</italic></td><td></td><td></td></tr><tr><td> rs2993531</td><td>172 (0.41)</td><td>203 (0.44)</td><td>1.95 (1.65–2.30)</td><td>5.20 × 10<sup>−05</sup></td><td>chr1</td><td>212190116</td><td>[A/C]</td><td><italic>INTS7</italic></td><td></td><td></td></tr><tr><td> rs2993531</td><td>172 (0.41)</td><td>203 (0.44)</td><td>1.95 (1.65–2.30)</td><td>5.20 × 10<sup>−05</sup></td><td>chr1</td><td>212190116</td><td>[A/C]</td><td><italic>INTS7</italic></td><td></td><td></td></tr><tr><td> rs34473884</td><td>172 (0.17)</td><td>203 (0.20)</td><td>0.40 (0.32–0.50)</td><td>6.15 × 10<sup>−05</sup></td><td>chr10</td><td>133761285</td><td>[A/G]</td><td><italic>PPP2R2D</italic></td><td></td><td></td></tr><tr><td> rs442800</td><td>172 (0.29)</td><td>203 (0.26)</td><td>1.98 (1.67–2.34)</td><td>5.53 × 10<sup>−05</sup></td><td>chr3</td><td>137786442</td><td>[T/C]</td><td><italic>DZIP1L</italic></td><td></td><td></td></tr><tr><td> rs4963128</td><td>172 (0.33)</td><td>203 (0.26)</td><td>0.49 (0.41–0.59)</td><td>8.00 × 10<sup>−05</sup></td><td>chr11</td><td>589564</td><td>[T/C]</td><td><italic>PHRF1</italic></td><td></td><td></td></tr><tr><td> rs6487927</td><td>172 (0.50)</td><td>203 (0.47)</td><td>2.21 (1.87–2.61)</td><td>1.58 × 10<sup>−06</sup></td><td>chr12</td><td>30826335</td><td>[T/C]</td><td><italic>IPO8</italic></td><td></td><td></td></tr><tr><td> rs6487928</td><td>172 (0.23)</td><td>203 (0.20)</td><td>2.53 (2.07–3.08)</td><td>2.99 × 10<sup>−06</sup></td><td>chr12</td><td>30828095</td><td>[A/G]</td><td><italic>IPO8</italic></td><td></td><td></td></tr><tr><td> rs7316477</td><td>172 (0.50)</td><td>203 (0.47)</td><td>2.22 (1.88–2.63)</td><td>1.50 × 10<sup>−06</sup></td><td>chr12</td><td>30786098</td><td>[A/G]</td><td><italic>IPO8</italic></td><td></td><td></td></tr><tr><td> rs750523</td><td>172 (0.39)</td><td>203 (0.38)</td><td>0.49 (0.41–0.58)</td><td>3.40 × 10<sup>−05</sup></td><td>chr2</td><td>108746221</td><td>[T/C]</td><td></td><td><italic>AC023672.1</italic> (30273)</td><td><italic>AC019100.3</italic> (37983)</td></tr><tr><td> rs756474</td><td>172 (0.23)</td><td>203 (0.32)</td><td>0.47 (0.39–0.57)</td><td>6.73 × 10<sup>−05</sup></td><td>chr8</td><td>95634950</td><td>[A/G]</td><td></td><td><italic>RP11-267M23.7</italic> (28121)</td><td><italic>RP11-22C11.2</italic> (14563)</td></tr><tr><td> rs7937152</td><td>172 (0.41)</td><td>203 (0.39)</td><td>1.95 (1.65–2.29)</td><td>4.44 × 10<sup>−05</sup></td><td>chr11</td><td>131936494</td><td>[T/C]</td><td><italic>NTM</italic></td><td></td><td></td></tr><tr><td> rs7944117</td><td>172 (0.39)</td><td>203 (0.41)</td><td>1.93 (1.65–2.26)</td><td>2.44 × 10<sup>−05</sup></td><td>chr11</td><td>40591800</td><td>[T/C]</td><td><italic>LRRC4C</italic></td><td></td><td></td></tr><tr><td> rs832665</td><td>171 (0.47)</td><td>203 (0.46)</td><td>0.50 (0.43–0.59)</td><td>4.22 × 10<sup>−05</sup></td><td>chr2</td><td>108731604</td><td>[T/C]</td><td></td><td><italic>AC023672.1</italic> (15656)</td><td><italic>AC019100.3</italic> (52600)</td></tr><tr><td> rs894943</td><td>172 (0.26)</td><td>203 (0.27)</td><td>0.49 (0.40–0.58)</td><td>8.80 × 10<sup>−05</sup></td><td>chr17</td><td>74916307</td><td>[A/G]</td><td><italic>MGAT5B</italic></td><td></td><td></td></tr><tr><td colspan="11"><italic>Hoarding dimension</italic></td></tr><tr><td> rs1010156</td><td>91 (0.62)</td><td>284 (0.45)</td><td>2.22 (1.83–2.69)</td><td>3.19 × 10<sup>−05</sup></td><td>chr8</td><td>23190941</td><td>[T/C]</td><td><italic>LOXL2</italic></td><td></td><td></td></tr><tr><td> rs10187022</td><td>91 (0.49)</td><td>284 (0.33)</td><td>2.13 (1.77–2.56)</td><td>4.71 × 10<sup>−05</sup></td><td>chr2</td><td>34341570</td><td>[A/C]</td><td><italic>AC009499.1</italic></td><td></td><td></td></tr><tr><td> rs12670403</td><td>91 (0.58)</td><td>284 (0.41)</td><td>2.35 (1.92–2.88)</td><td>2.37 × 10<sup>−05</sup></td><td>chr7</td><td>17309279</td><td>[A/C]</td><td></td><td><italic>AC098592.8</italic> (236177)</td><td><italic>AC003075.4</italic> (10179)</td></tr><tr><td> rs13068223</td><td>91 (0.35)</td><td>284 (0.52)</td><td>0.44 (0.36–0.53)</td><td>2.13 × 10<sup>−05</sup></td><td>chr3</td><td>156470955</td><td>[A/G]</td><td><italic>LINC00886</italic></td><td></td><td></td></tr><tr><td> rs1469064</td><td>91 (0.49)</td><td>284 (0.32)</td><td>2.39 (1.97–2.92)</td><td>9.95 × 10<sup>−06</sup></td><td>chr5</td><td>164859465</td><td>[T/C]</td><td><italic>CTC-535M15.2</italic></td><td></td><td></td></tr><tr><td> rs17137472</td><td>91 (0.58)</td><td>284 (0.41)</td><td>2.26 (1.85–2.76)</td><td>4.71 × 10<sup>−05</sup></td><td>chr7</td><td>17296072</td><td>[T/C]</td><td></td><td><italic>AC098592.8</italic> (222970)</td><td><italic>AC003075.4</italic> (23386)</td></tr><tr><td> rs1807512</td><td>90 (0.46)</td><td>282 (0.31)</td><td>2.16 (1.78–2.63)</td><td>9.10 × 10<sup>−05</sup></td><td>chr22</td><td>17221495</td><td>[T/C]</td><td></td><td><italic>VWFP1</italic> (36128)</td><td><italic>AC005301.8</italic> (6264)</td></tr><tr><td> rs1944828</td><td>91 (0.21)</td><td>284 (0.10)</td><td>2.92 (2.25–3.80)</td><td>4.53 × 10<sup>−05</sup></td><td>chr11</td><td>127048359</td><td>[T/C]</td><td></td><td><italic>CTD-2234N14.2</italic> (38729)</td><td><italic>CTD-2234N14.1</italic> (12305)</td></tr><tr><td> rs285714</td><td>91 (0.40)</td><td>284 (0.26)</td><td>2.24 (1.84–2.73)</td><td>4.67 × 10<sup>−05</sup></td><td>chr15</td><td>93126781</td><td>[T/C]</td><td><italic>RP11–386M24.3</italic></td><td></td><td></td></tr><tr><td> rs4143121</td><td>91 (0.45)</td><td>284 (0.31)</td><td>2.29 (1.88–2.80)</td><td>3.16 × 10<sup>−05</sup></td><td>chr3</td><td>1764453</td><td>[T/C]</td><td></td><td><italic>AC090043.1</italic> (126524)</td><td><italic>RPL23AP39</italic> (7301)</td></tr><tr><td> rs7326856</td><td>91 (0.43)</td><td>283 (0.26)</td><td>2.12 (1.77–2.55)</td><td>4.16 × 10<sup>−05</sup></td><td>chr13</td><td>66338922</td><td>[T/C]</td><td></td><td><italic>STARP1</italic> (453837)</td><td><italic>HNRNPA3P5</italic> (23142)</td></tr><tr><td> rs956818</td><td>91 (0.18)</td><td>284 (0.35)</td><td>0.37 (0.30–0.47)</td><td>1.41 × 10<sup>−05</sup></td><td>chr16</td><td>6537353</td><td>[T/G]</td><td><italic>RP11-420N3.2</italic></td><td></td><td></td></tr><tr><td> rs956818</td><td>91 (0.18)</td><td>284 (0.35)</td><td>0.37 (0.30–0.47)</td><td>1.41 × 10<sup>−05</sup></td><td>chr16</td><td>6537353</td><td>[T/G]</td><td><italic>RBFOX1</italic></td><td></td><td></td></tr><tr><td> rs9575590</td><td>91 (0.33)</td><td>284 (0.52)</td><td>0.42 (0.35–0.51)</td><td>4.47 × 10<sup>−06</sup></td><td>chr13</td><td>85066303</td><td>[A/G]</td><td></td><td><italic>UBE2D3P4</italic> (471406)</td><td><italic>MTND4P1</italic> (27935)</td></tr><tr><td colspan="11"><italic>Sexual/ religious dimension</italic></td></tr><tr><td> rs10076327</td><td>95 (0.44)</td><td>280 (0.27)</td><td>2.41 (1.96–2.97)</td><td>2.12 × 10<sup>−05</sup></td><td>chr5</td><td>122367347</td><td>[A/G]</td><td><italic>PPIC</italic></td><td></td><td></td></tr><tr><td> rs10408163</td><td>95 (0.41)</td><td>279 (0.26)</td><td>2.24 (1.83–2.73)</td><td>5.49 × 10<sup>−05</sup></td><td>chr19</td><td>47597102</td><td>[T/C]</td><td><italic>ZC3H4</italic></td><td></td><td></td></tr><tr><td> rs10804925</td><td>95 (0.55)</td><td>280 (0.39)</td><td>2.11 (1.75–2.55)</td><td>7.39 × 10<sup>−05</sup></td><td>chr3</td><td>190094024</td><td>[A/G]</td><td><italic>CLDN16</italic></td><td></td><td></td></tr><tr><td> rs10902225</td><td>95 (0.28)</td><td>280 (0.45)</td><td>0.47 (0.39–0.57)</td><td>9.14 × 10<sup>−05</sup></td><td>chr11</td><td>835065</td><td>[T/C]</td><td><italic>CD151</italic></td><td></td><td></td></tr><tr><td> rs11128702</td><td>95 (0.33)</td><td>280 (0.20)</td><td>2.33 (1.89–2.88)</td><td>6.31 × 10<sup>−05</sup></td><td>chr3</td><td>14530133</td><td>[T/C]</td><td><italic>SLC6A6</italic></td><td></td><td></td></tr><tr><td> rs11131820</td><td>95 (0.46)</td><td>280 (0.29)</td><td>2.16 (1.79–2.60)</td><td>3.48 × 10<sup>−05</sup></td><td>chr4</td><td>178683325</td><td>[T/C]</td><td><italic>LINC01098</italic></td><td></td><td></td></tr><tr><td> rs12213157</td><td>95 (0.32)</td><td>280 (0.18)</td><td>2.31 (1.88–2.84)</td><td>5.22 × 10<sup>−05</sup></td><td>chr6</td><td>163640489</td><td>[A/G]</td><td><italic>PACRG</italic></td><td></td><td></td></tr><tr><td> rs12552120</td><td>95 (0.36)</td><td>280 (0.51)</td><td>0.47 (0.38–0.57)</td><td>8.87 × 10<sup>−05</sup></td><td>chr9</td><td>90514482</td><td>[T/C]</td><td></td><td><italic>SPATA31E1</italic> (10668)</td><td><italic>SPATA31C1</italic> (14926)</td></tr><tr><td> rs12929114</td><td>95 (0.55)</td><td>280 (0.37)</td><td>2.18 (1.80–2.63)</td><td>3.79 × 10<sup>−05</sup></td><td>chr16</td><td>65532244</td><td>[T/C]</td><td><italic>LINC00922</italic></td><td></td><td></td></tr><tr><td> rs1441537</td><td>95 (0.11)</td><td>280 (0.24)</td><td>0.32 (0.25–0.42)</td><td>2.34 × 10<sup>−05</sup></td><td>chr5</td><td>3261155</td><td>[T/C]</td><td></td><td><italic>CTD-2029E14.1</italic> (79809)</td><td><italic>LINC01019</italic> (156111)</td></tr><tr><td> rs144597</td><td>94 (0.46)</td><td>280 (0.29)</td><td>2.17 (1.79–2.64)</td><td>6.90 × 10<sup>−05</sup></td><td>chr5</td><td>122223232</td><td>[A/C]</td><td><italic>SNX24</italic></td><td></td><td></td></tr><tr><td> rs1460040</td><td>95 (0.42)</td><td>280 (0.26)</td><td>2.30 (1.87–2.82)</td><td>5.59 × 10<sup>−05</sup></td><td>chr5</td><td>122105232</td><td>[A/G]</td><td></td><td><italic>RP11-166A12.1</italic> (38852)</td><td><italic>SNX2</italic> (5459)</td></tr><tr><td> rs1606502</td><td>95 (0.58)</td><td>280 (0.44)</td><td>2.13 (1.76–2.58)</td><td>7.95 × 10<sup>−05</sup></td><td>chr8</td><td>57529208</td><td>[T/C]</td><td></td><td><italic>RP11-17A4.1</italic> (27862)</td><td><italic>RP11-17A4.4</italic> (23252)</td></tr><tr><td> rs16871518</td><td>95 (0.14)</td><td>280 (0.29)</td><td>0.35 (0.28–0.45)</td><td>1.76 × 10<sup>−05</sup></td><td>chr5</td><td>3254413</td><td>[T/C]</td><td></td><td><italic>CTD-2029E14.1</italic> (73067)</td><td><italic>LINC01019</italic> (162853)</td></tr><tr><td> rs17023204</td><td>95 (0.28)</td><td>280 (0.17)</td><td>2.43 (1.94–3.04)</td><td>7.53 × 10<sup>−05</sup></td><td>chr4</td><td>148329646</td><td>[T/C]</td><td></td><td><italic>MIR548G</italic> (63777)</td><td><italic>RP11–364M6.1</italic> (17480)</td></tr><tr><td> rs17635830</td><td>95 (0.09)</td><td>280 (0.24)</td><td>0.32 (0.24–0.42)</td><td>4.30 × 10<sup>−05</sup></td><td>chr17</td><td>52847941</td><td>[T/C]</td><td></td><td><italic>ARL2BPP8</italic> (15931)</td><td><italic>RN7SKP14</italic> (369)</td></tr><tr><td> rs2303108</td><td>95 (0.39)</td><td>280 (0.25)</td><td>2.23 (1.82–2.73)</td><td>7.46 × 10<sup>−05</sup></td><td>chr19</td><td>47589895</td><td>[T/C]</td><td><italic>ZC3H4</italic></td><td></td><td></td></tr><tr><td> rs2303108</td><td>95 (0.39)</td><td>280 (0.25)</td><td>2.23 (1.82–2.73)</td><td>7.46 × 10<sup>−05</sup></td><td>chr19</td><td>47589895</td><td>[T/C]</td><td><italic>ZC3H4</italic></td><td></td><td></td></tr><tr><td> rs2345493</td><td>95 (0.14)</td><td>280 (0.29)</td><td>0.37 (0.29–0.47)</td><td>2.95 × 10<sup>−05</sup></td><td>chr2</td><td>18292201</td><td>[T/G]</td><td><italic>KCNS3</italic></td><td></td><td></td></tr><tr><td> rs2826856</td><td>95 (0.29)</td><td>280 (0.15)</td><td>2.42 (1.96–2.99)</td><td>2.67 × 10<sup>−05</sup></td><td>chr21</td><td>22842175</td><td>[A/G]</td><td><italic>NCAM2</italic></td><td></td><td></td></tr><tr><td> rs35521</td><td>95 (0.36)</td><td>280 (0.20)</td><td>2.33 (1.90–2.87)</td><td>4.29 × 10<sup>−05</sup></td><td>chr5</td><td>107081478</td><td>[A/G]</td><td></td><td><italic>RN7SL782P</italic> (10711)</td><td><italic>RN7SKP122</italic> (64852)</td></tr><tr><td> rs3844159</td><td>95 (0.26)</td><td>280 (0.13)</td><td>2.43 (1.94–3.04)</td><td>8.07 × 10<sup>−05</sup></td><td>chr10</td><td>60733376</td><td>[T/C]</td><td></td><td><italic>RN7SKP196</italic> (104088)</td><td><italic>LINC00844</italic> (26010)</td></tr><tr><td> rs4685147</td><td>95 (0.62)</td><td>280 (0.44)</td><td>2.30 (1.90–2.78)</td><td>1.23 × 10<sup>−05</sup></td><td>chr3</td><td>14424656</td><td>[T/C]</td><td></td><td><italic>RP11–536I6.1</italic> (30588)</td><td><italic>RNA5SP124</italic> (11492)</td></tr><tr><td> rs4853954</td><td>95 (0.49)</td><td>280 (0.32)</td><td>2.06 (1.72–2.47)</td><td>6.58 × 10<sup>−05</sup></td><td>chr2</td><td>2935910</td><td>[T/C]</td><td><italic>AC019118.2</italic></td><td></td><td></td></tr><tr><td> rs62136856</td><td>95 (0.41)</td><td>280 (0.26)</td><td>2.26 (1.85–2.76)</td><td>4.17 × 10<sup>−05</sup></td><td>chr19</td><td>47573527</td><td>[A/G]</td><td><italic>ZC3H4</italic></td><td></td><td></td></tr><tr><td> rs7470248</td><td>95 (0.36)</td><td>280 (0.51)</td><td>0.47 (0.38–0.57)</td><td>8.87 × 10<sup>−05</sup></td><td>chr9</td><td>90515619</td><td>[A/G]</td><td></td><td><italic>SPATA31E1</italic> (11805)</td><td><italic>SPATA31C1</italic> (13789)</td></tr><tr><td> rs974728</td><td>95 (0.21)</td><td>278 (0.36)</td><td>0.41 (0.33–0.51)</td><td>4.59 × 10<sup>−05</sup></td><td>chr12</td><td>11934852</td><td>[A/G]</td><td><italic>X10TV6</italic></td><td></td><td></td></tr></tbody></table><table-wrap-foot><p><italic>SNP</italic> single nucleotide polymorphism, <italic>MAF</italic> minor allele frequency, <italic>OR (CI)</italic>, odds ratio (confidence interval); <italic>A1/A2</italic> allele 1, allele 2, <italic>CHR</italic>. chromosome, <italic>BP</italic> base pairs.</p></table-wrap-foot></table-wrap></p>
<p id="Par24">In the order dimension, eight variants presented suggestive associations (<italic>p</italic> &lt; 10<sup>−5</sup>). Six of these variants were within chromosome 12 and, given the proximity between them (5 of them were variants of the <italic>IPO8</italic> gene), we performed LD analysis on this region. We found two clusters of SNPs: (1) rs7316477 (1.50 × 10<sup>−6</sup>), rs14139 (1.50 × 10<sup>−6</sup>), rs6487927 (1.58 × 10<sup>−6</sup>) and rs10771752 (1.83 × 10<sup>−6</sup>), all exonic variants located in the <italic>IPO8</italic> (Importin 8) gene (Fig. <xref ref-type="fig" rid="Fig2">2a</xref>); and (2) rs6487928 (2.99 × 10<sup>−6</sup>) and rs12146709 (3.70 × 10<sup>−6</sup>), exonic variants located in <italic>IPO8</italic> and <italic>CAPRIN2</italic> (Caprin Family Member 2), respectively (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). All these markers should be considered as forming a single association peak, since the level of association was not maintained for any of them when adjusting the model for each of the other markers.<fig id="Fig2"><label>Fig. 2</label><caption><title>Regional association plots with LD reported for Order dimension-suggestively associated (<italic>p</italic> &lt; 10<sup>-5</sup>) single-nucleotide polymorphisms (SNPs) in chromosome 12.</title><p><bold>a</bold> Plot of rs7316477. <bold>b</bold> Plot of rs6487928.</p></caption><graphic id="d29e4563" xlink:href="41398_2020_804_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec11">
<title>Gene-based association analyses</title>
<p id="Par25">Gene-based analysis were performed for 22,017 (aggressive), 21,179 (order), 20,466 (contamination) and 22,472 (hoarding and sexual/religious) genes. Of these, 17,001 (aggressive), 16,467 (order), 15,790 (contamination), and 17,378 (hoarding and sexual/religious) had at least two genotyped markers and were considered in our further analyses.</p>
<p id="Par26">Our results for genes with at least a suggestive association (<italic>p</italic> &lt; 10<sup>−4</sup>) in the five dimensions can be seen in Table <xref ref-type="table" rid="Tab3">3</xref>. One gene reached genome-wide significant association with hoarding (SET Domain Containing 3, Actin Histidine Methyltransferase, <italic>SETD3</italic>; <italic>p</italic> = 1.89 × 10<sup>−08</sup>). This gene codes for a protein involved, among other functions, in actin binding and modification, histone methylation, chromatin organization, and regulation of transcription<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. The second most significant gene was <italic>CPE</italic> (Carboxypeptidase E), which reached genome-wide significant association with the aggressive dimension (<italic>p</italic> = 4.42 × 10<sup>−6</sup>). This gene codes for a membrane protein involved in the synthesis of peptide hormones and neurotransmitters as well as different neurotrophic functions<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Best gene-based results from SKAT analyses for the different OCD dimensions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th><italic>P</italic></th><th>QMETA</th><th>CMAF</th><th>NSNPS</th></tr></thead><tbody><tr><td colspan="5">Aggressive</td></tr><tr><td>
<italic> CPE</italic></td><td><bold>4.42</bold> × <bold>10</bold><sup><bold>−06</bold></sup></td><td>10 857.8</td><td>4.18</td><td>15</td></tr><tr><td>
<italic> HIST1H2AH</italic></td><td>5.13 × 10<sup>−05</sup></td><td>9 329.72</td><td>0.03</td><td>2</td></tr><tr><td>
<italic> FOXP4</italic></td><td>1.01 × 10<sup>−05</sup></td><td>11 790.03</td><td>1.48</td><td>8</td></tr><tr><td>
<italic> CREB5</italic></td><td>9.29 × 10<sup>−05</sup></td><td>6 440.17</td><td>2.87</td><td>12</td></tr><tr><td colspan="5">Order</td></tr><tr><td>
<italic> PPP2R2D</italic></td><td>6.54 × 10<sup>−05</sup></td><td>23.49</td><td>0.65</td><td>3</td></tr><tr><td colspan="5">Hoarding</td></tr><tr><td>
<italic> SERINC2</italic></td><td>8.17 × 10<sup>−05</sup></td><td>10 941.25</td><td>0.26</td><td>9</td></tr><tr><td>
<italic> SETD3</italic></td><td><bold>1.89</bold> × <bold>10</bold><sup><bold>−08</bold></sup></td><td>16 579.98</td><td>0.64</td><td>3</td></tr><tr><td colspan="5">Sexual/Religious</td></tr><tr><td>
<italic> CDC42BPA</italic></td><td>4.97 × 10<sup>−05</sup></td><td>7 002.15</td><td>6.61</td><td>27</td></tr><tr><td>
<italic> GPR137B</italic></td><td>3.65 × 10<sup>−05</sup></td><td>18 669.76</td><td>2.24</td><td>15</td></tr><tr><td>
<italic> LYZL4</italic></td><td>3.48 × 10<sup>−05</sup></td><td>9 965.91</td><td>0.07</td><td>3</td></tr><tr><td>
<italic> ABR</italic></td><td>9.13 × 10<sup>−05</sup></td><td>7 283.78</td><td>1.81</td><td>7</td></tr></tbody></table><table-wrap-foot><p><italic>CMAF</italic> collected minor allele fruequency, <italic>QMETA</italic> test score reported by SKAT. Bold text highlights significant associations at a gene-based analysis level.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec12">
<title>Functional annotation</title>
<p id="Par27">Functional annotation was gathered for a final set of 154 (aggressive), 103 (contamination), 111 (order), 196 (hoarding) and 167 (sexual/religious) genes. The threshold used to select the genes included in the enrichment analyses (<italic>p</italic> &lt; 0.01) included 1% of the genes in all the dimensions except the hoarding dimension, for which 2% of the genes presented a <italic>p</italic>-value lower than 0.01.</p>
<p id="Par28">Detailed information on the results of these analyses are given in Tables <xref ref-type="table" rid="Tab4">4</xref> and <xref ref-type="table" rid="Tab5">5</xref>. In the case of the hoarding dimension, the different pathways obtained are clustered in two groups according to their biological similarity.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Results from enrichment analyses on Aggressive, Order and Sexual/religious dimensions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Category</th><th>Term</th><th>Count (%)</th><th><italic>P</italic>-value</th><th>Genes</th><th>List total</th><th>Fold enrichment</th><th>FDR</th></tr></thead><tbody><tr><td colspan="8"><italic>Aggressive</italic></td></tr><tr><td> GOTERM_BP_DIRECT</td><td>GO:0010043~response to zinc ion</td><td>5 (3.29)</td><td>1.52 × 10<sup>−04</sup></td><td>ALAD, ASS1, SLC30A8, CPS1, SLC30A6</td><td>128</td><td>18.22</td><td>0.002</td></tr><tr><td> REACTOME_PATHWAY</td><td>R-HSA-390918 (<italic>Peroxisomal lipid metabolism</italic>)</td><td>3 (1.97)</td><td>0.002</td><td>MLYCD, NUDT7, ACBD4</td><td>72</td><td>47.27</td><td>0.020</td></tr><tr><td colspan="8"><italic>Order</italic></td></tr><tr><td> KEGG_PATHWAY</td><td>hsa04071:Sphingolipid signaling pathway</td><td>5 (4.63)</td><td>0.002</td><td>BID, CERS6, BDKRB2, PPP2R2D, ASAH1</td><td>33</td><td>8.69</td><td>0.025</td></tr><tr><td colspan="8"><italic>Sexual/religious</italic></td></tr><tr><td> REACTOME_PATHWAY</td><td>R-HSA-416482 (<italic>G alpha (12/13) signalling events)</italic></td><td>5 (3.03)</td><td>0.003</td><td>ABR, RAC1, SOS2, ADRA1A, GNB5</td><td>69</td><td>8.54</td><td>0.032</td></tr></tbody></table><table-wrap-foot><p><italic>Count</italic> number of OCD genes involved in the pathway/ biological process, <italic>List total</italic> total number of genes involved in the pathway/process, <italic>FDR</italic> false discovery rate.</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Results from enrichment analyses on Hoarding dimension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Annotation Cluster 1</th><th colspan="7">Enrichment Score: 6.97</th></tr><tr><th>Category</th><th>Term</th><th>Count (%)</th><th><italic>P</italic>-value</th><th>Genes</th><th>List total</th><th>Fold enrichment</th><th>FDR</th></tr></thead><tbody><tr><td>GOTERM_BP_DIRECT</td><td>GO:2001030~negative regulation of cellular glucuronidation</td><td>8 (3.90)</td><td>9.39 × 10<sup>−14</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A4, UGT1A1</td><td>176</td><td>95.41</td><td>1.74 × 10<sup>−14</sup></td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:1904224~negative regulation of glucuronosyltransferase activity</td><td>8 (3.90)</td><td>9.39 × 10<sup>−14</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A4, UGT1A1</td><td>176</td><td>95.41</td><td>1.47 × 10<sup>−12</sup></td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:0045922~negative regulation of fatty acid metabolic process</td><td>8 (3.90)</td><td>4.19 × 10<sup>−13</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A4, UGT1A1</td><td>176</td><td>84.81</td><td>6.57 × 10<sup>−12</sup></td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:0052695~cellular glucuronidation</td><td>8 (3.90)</td><td>1.25 × 10<sup>−10</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A4, UGT1A1</td><td>176</td><td>47.70</td><td>1.96 × 10<sup>−09</sup></td></tr><tr><td>KEGG_PATHWAY</td><td>hsa00053:Ascorbate and aldarate metabolism</td><td>9 (4.39)</td><td>2.86 × 10<sup>−10</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1</td><td>77</td><td>29.78</td><td>3.33 × 10<sup>−09</sup></td></tr><tr><td>REACTOME_PATHWAY</td><td>R-HSA-156588 (<italic>Glucuronidation</italic>)</td><td>8 (3.90)</td><td>5.67 × 10<sup>−10</sup></td><td>UGT1A7, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1</td><td>104</td><td>38.78</td><td>7.06 × 10<sup>−09</sup></td></tr><tr><td>KEGG_PATHWAY</td><td>hsa00040:Pentose and glucuronate interconversions</td><td>9 (4.39)</td><td>1.69 × 10<sup>−09</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1</td><td>77</td><td>24.36</td><td>1.97 × 10<sup>−08</sup></td></tr><tr><td>KEGG_PATHWAY</td><td>hsa00140:Steroid hormone biosynthesis</td><td>10 (4.88)</td><td>1.04 × 10<sup>−08</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1, CYP19A1</td><td>77</td><td>15.40</td><td>1.21 × 10<sup>−07</sup></td></tr><tr><td>KEGG_PATHWAY</td><td>hsa00860:Porphyrin and chlorophyll metabolism</td><td>9 (4.39)</td><td>1.33 × 10<sup>−08</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1</td><td>77</td><td>19.14</td><td>1.55 × 10<sup>−07</sup></td></tr><tr><td>KEGG_PATHWAY</td><td>hsa00830:Retinol metabolism</td><td>9 (4.39)</td><td>4.11 × 10<sup>−07</sup></td><td>UGT1A7, UGT1A10, UGT1A6, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, UGT1A1</td><td>77</td><td>12.56</td><td>4.78 × 10<sup>−06</sup></td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:0042573~retinoic acid metabolic process</td><td>5 (2.44)</td><td>1.05 × 10<sup>−05</sup></td><td>UGT1A7, UGT1A9, UGT1A8, UGT1A3, UGT1A1</td><td>176</td><td>34.07</td><td>1.65 × 10<sup>−4</sup></td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:0008152~metabolic process</td><td>11 (5.37)</td><td>1.06 × 10<sup>−05</sup></td><td>UGT1A7, UGT1A10, UGT1A6, ACSM1, UGT1A9, UGT1A8, UGT1A3, UGT1A5, UGT1A4, GALNS, UGT1A1</td><td>176</td><td>6.25</td><td>1.67 × 10<sup>−4</sup></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th>Annotation Cluster 2</th><th colspan="7">Enrichment Score: 2.96</th></tr><tr><th>Category</th><th>Term</th><th>Count</th><th><italic>P-value</italic></th><th>Genes</th><th>List total</th><th>Fold enrichment</th><th>FDR</th></tr></thead><tbody><tr><td>GOTERM_BP_DIRECT</td><td>GO:0019532~oxalate transport</td><td>4 (1.95)</td><td>1.73 × 10<sup>−04</sup></td><td>SLC26A6, SLC26A5, SLC26A10, SLC26A2</td><td>176</td><td>34.69</td><td>0.003</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:1902358~sulfate transmembrane transport</td><td>4 (1.95)</td><td>2.28 × 10<sup>−04</sup></td><td>SLC26A6, SLC26A5, SLC26A10, SLC26A2</td><td>176</td><td>31.80</td><td>0.004</td></tr><tr><td>GOTERM_BP_DIRECT</td><td>GO:0015701~bicarbonate transport</td><td>5 (2.44)</td><td>0.001</td><td>SLC26A6, SLC26A5, CFTR, SLC26A10, SLC26A2</td><td>176</td><td>10.84</td><td>0.017</td></tr></tbody></table><table-wrap-foot><p><italic>Count</italic> number of OCD genes involved in the pathway/ biological process, <italic>List total</italic> total number of genes involved in the pathway/process; FDR, false discovery rate.</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec13" sec-type="discussion">
<title>Discussion</title>
<p id="Par29">In this study, we examined the genomic bases of each of the most consistently validated symptom dimensions of OCD. Differential findings were obtained for the five dimensions considered. At the SNP-level, no variant reached genome-wide significance. The top SNPs were six markers in the order dimension (forming a single association peak) and one variant in the hoarding dimension (<italic>p</italic> &lt; 5 × 10<sup>−6</sup>). Gene analyses showed one gene associated with hoarding (<italic>SETD3</italic>, <italic>p</italic> = 1.89 × 10<sup>−8</sup>) and another with the aggressive dimension (<italic>CPE</italic>, <italic>p</italic> = 4.42 × 10<sup>−6</sup>) at a genome-wide level. Different pathways or biological processes were represented by the aggressive, order, sexual/religious, and hoarding dimensions. For contamination, no pathway remained associated after FDR correction.</p>
<p id="Par30">Six of the top variants at the SNP-level analysis conformed a genomic region involving <italic>IPO8</italic> and <italic>CAPRIN2</italic>, which presented an association signal with the order dimension. Certain intergenic variants near <italic>CAPRIN2</italic> presented association signals (<italic>p</italic> &lt; 5 × 10<sup>−5</sup>) with different neuropsychological variables and personality traits (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000342.v18.p11">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000342.v18.p11</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000338.v1.p1">https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000338.v1.p1</ext-link>). Considering the LD findings for this region and the fact that the six variants represent a single peak of association, it may be interesting to consider this genomic region in further studies, since it could be a relevant for the order dimension.</p>
<p id="Par31">Gene-based analyses reported one gene associated with hoarding at the genome-wide significance level (<italic>SETD3</italic>, <italic>p</italic> = 1.89 × 10<sup>−8</sup>). That gene is expressed in brain regions associated with OCD<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup> such as caudate and cerebellum (The Human Protein Atlas, <italic>SETD3</italic>, gene available from <ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/ENSG00000183576-SETD3/tissue">https://www.proteinatlas.org/ENSG00000183576-SETD3/tissue</ext-link>) and seems to mediate transcriptome changes in the hypothalamus of mice<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. It has also been associated with apoptotic processes, which in turn have been observed to mediate the neuronal loss in certain brain regions of BD patients<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Although two SNPs located near <italic>SETD3</italic> show suggestive associations with autoimmune and inflammatory conditions (rs2614463, <italic>P</italic> = 7.00 × 10<sup>−6</sup>; rs2664299, <italic>P</italic> = 9.00 × 10<sup>−6</sup>), none of them are in LD with any of the <italic>SETD3</italic> variants in our analysis—rs12886549 (<italic>P</italic> = 0.68, MAF = 0.24, OR = 1.09); rs8015827 (<italic>P</italic> = 0.79; MAF = 0.39; OR = 1.05); rs34322735 (<italic>P</italic> = 1.72 × 10-08, MAF = 0.01, OR = 101.39). <italic>CPE</italic>, which was associated with the aggressive dimension, is a gene highly expressed in brain<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Different polymorphisms in this gene have been associated with a loss of neuroprotective function by reducing the effects of the oxidative stress in human cell lines<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> and transgenic mice<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, leading to memory deficits and depressive behavior<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. In addition, <italic>CPE</italic>-knockout mice have shown neurodegeneration in the hippocampus and the prefrontal cortex<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p>
<p id="Par32">In relation to the aggressive dimension, enrichment analyses showed overrepresentation in <italic>response to zinc ions</italic> (GO:0010043, FDR = 0.002). Zinc ions are highly prevalent in the brain, being especially prominent in forebrain glutamatergic neurons, the hippocampus, and the amygdala<sup><xref ref-type="bibr" rid="CR58">58</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>, and they plays an important role in neuronal plasticity<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Zinc deficiency has been associated with cognitive decline, Alzheimer’s disease (AD) and different psychiatric disorders in the elderly. In addition, genetic variants within <italic>ZNF142</italic>, a gene coding for a zinc-finger protein, have been associated with a neurodevelopmental disorder resulting in speech impairment and intellectual disability<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. The <italic>Peroxisomal lipid metabolism</italic> pathway (R-HSA-390918) was also significantly enriched in the aggressive dimension. Lipid metabolism has been extensively associated with different neuropsychiatric disorders, such as BD and depressive disorders, as well as AD<sup><xref ref-type="bibr" rid="CR62">62</xref>–<xref ref-type="bibr" rid="CR65">65</xref></sup>. Similarly, the <italic>sphingolipid signaling pathway</italic> (hsa04071) appears overrepresented in the order dimension. Sphingolipids are structural elements of cellular membranes and they play a role in cell signaling, differentiation and proliferation, apoptotic processes and inflammation<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Sphingolipid signaling has been observed to be involved in anxiety-like behavior in animal models as well as schizophrenia, depression and BD<sup><xref ref-type="bibr" rid="CR66">66</xref>–<xref ref-type="bibr" rid="CR69">69</xref></sup>.</p>
<p id="Par33">Sexual/religious dimension genes were found enriched for <italic>G alpha (12/13) signaling events</italic> (R-HSA-416482). G12/13 subunits are alpha units of heterotrimeric G proteins that regulate different cell processes through the use of guanine nucleotide exchange factors (GEFs). This family of G-protein subunits has been associated with neurodevelopment and is involved in processes of cell proliferation and migration<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. In addition, G12 subunits have been observed to influence memory consolidation and contextual retrieval in mice, via increased expression in the hippocampus<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>.</p>
<p id="Par34">For the hoarding dimension, the first cluster of biological mechanisms and pathways includes cellular metabolic processes, such as lipid, vitamin and carbohydrate metabolism, all involving glucuronidation processes, as most genes included in these mechanisms or pathways code for UDP-glucuronosyltransferases (Table <xref ref-type="table" rid="Tab5">5</xref>). It has been demonstrated that an alteration of the activity of these enzymes can affect brain function<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. As an example, induction of UDP-glucuronosyltransferase 1A1 during the prenatal period can cause neurodevelopmental disorders in mice<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>.</p>
<p id="Par35">There is increasing evidence from metabolomic studies of the importance of metabolic processes in psychiatric disorders. Post-traumatic stress disorder (PTSD) has been associated with the alteration of different kinds of metabolites, such as monosaccharides, nucleosides or fatty acids<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. Furthermore, there is evidence of dysfunctional metabolism of lipids and vitamins in depressed patients<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, which may explain the high prevalence of comorbid metabolic syndrome and cardiovascular disease<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>.</p>
<p id="Par36">A lower plasma concentration of certain lipids with a neuroprotective role also has been observed in PTSD patients, compared to healthy controls<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Altered lipid metabolism has been found in other psychiatric conditions, such as MDD, BD or schizophrenia, and associated with symptoms including anxiety, stress and cognitive impairment<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. Lipid metabolism in turn influences steroid synthesis, which has been associated with brain electrical activity through the role of lipids in modulating neuronal excitability<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. In addition, an alteration of porphyrin and chlorophyll metabolism might affect the formation of heme groups, possibly leading to neurotoxic effects, among others<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR81">81</xref></sup>.</p>
<p id="Par37">The second cluster of biological mechanisms and pathways for the hoarding dimension is related to anion transport. Most of the hoarding dimension genes involved are members of the solute-carrier 26 family A (SLC26A). These transporters have been observed to influence, among other functions, microbiome composition, pH regulation, and anion transport<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>, which in turn have been related with the pathophysiology of different psychiatric disorders<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. More specifically, anion transport and pH regulation in the brain play a role in intra- and inter-signaling and plasticity processes<sup><xref ref-type="bibr" rid="CR84">84</xref></sup>. In relation to microbiome composition, late-onset autism has been associated with differences in the gastrointestinal microflora when compared to healthy controls<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. Moreover, exposure to certain microbial pathogens during fetal development has been associated with the pathogenesis of schizophrenia in humans<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>, and both anxiety-like behavior and cognitive impairment in rodents<sup><xref ref-type="bibr" rid="CR87">87</xref>,<xref ref-type="bibr" rid="CR88">88</xref></sup>. It is interesting to note the increase in the genetic weight observed in the hoarding dimension when the rare variants are included in the analysis, since only two variants at the SNP level reach suggestive association and no SNP reaches genome-wide significance. This contrasts with the findings obtained for this dimension in the gene-based and pathway analyses, which are notably more numerous than for the other dimensions. We think this suggests a role for rare variants in the hoarding dimension. We also believe that the consistently observed higher heritability of this dimension, compared to the others<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR89">89</xref>,<xref ref-type="bibr" rid="CR90">90</xref></sup>, could mostly be explained by the influence of rare variants. Further research is needed to reveal the genetic bases of the hoarding dimension.</p>
<p id="Par38">Although OCD symptom dimensions overcome the unitary clinical diagnosis of OCD, subtyping OCD according to overt clinical manifestations also presents significant limitations. Due to methodological differences, no concrete OCD dimensions classification system has been universally accepted. Some authors argue that other taxometric methods should be used to elucidate the symptom dimensions in OCD, including age of onset, comorbidities, or neuropsychological functioning in combination with clinical manifestations. The lack of significant associations among OCD symptom dimensions and individual SNPs could reflect limited statistical power due to the small sample size. Considering our total sample size, the number of cases and controls for each OCD dimension, a significance threshold of <italic>p</italic> &lt; 2 × 10<sup>−7</sup> (Bonferroni threshold for 258,000 SNPs analyzed) and a risk allele frequency (MAF) of 0.1, our study has 80% power to detect a relative risk (RR) of 3.5 and 5 (equivalent to OR = 4.8 and OR = 9) for order and sexual/religious dimensions, respectively; for the three other OCD dimensions, the detectable RR under these conditions is 4 (equivalent to OR = 6). A representation of the statistical power achieved for different MAF and RR thresholds is shown in Supplementary Fig. <xref ref-type="media" rid="MOESM1">1</xref> (Fig. <xref ref-type="media" rid="MOESM1">S1a–e</xref>). Furthermore, we would have liked to consider the severity score for each dimension in our analysis, in addition to their presence/absence, which would have been possible with a larger sample. However, our sample was thoroughly characterized phenotypically, and our results highlight important differences in relation to the genetic bases, as well as the genetic load of the different OCD dimensions. In addition, rare variants are considered at gene-based and pathway analyses, since this kind of analysis increases the power of detecting small effects. The inclusion of rare variants is important given the growing appreciation for their importance in neuropsychiatric disorders<sup><xref ref-type="bibr" rid="CR91">91</xref>–<xref ref-type="bibr" rid="CR93">93</xref></sup>.</p>
<p id="Par39">OCD is a highly heterogeneous disorder in terms of symptom profile, comorbidity and underlying brain substrate, which represents a challenge for understanding and treating the disorder. This heterogeneity may confound and contribute to mostly negative findings in current genome-wide analysis studies, despite clear evidence for a strong genetic component of the disorder based on twin and family studies, ranging from 40–65%. Therefore, broad consensus has emerged for the need to explore OCD not as a homogeneous diagnosis, but rather considering other phenomenological approaches that investigate more refined phenotypes. In this sense, investigating genetic markers associated with different OCD symptom dimensions could be a useful strategy to begin disentangling the complex genetic vulnerability of the disorder. A clearer identification of susceptibility genes for OCD would translate into a better understanding of the etiology of the disorder and would help to develop potentially targeted and specific treatment approaches to improve the long-term outcome for OCD patients.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec14">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41398_2020_804_MOESM1_ESM.docx"><caption><p>Supplementary Figure 1 (Figure S1)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary Information</bold> accompanies this paper at (10.1038/s41398-020-0804-z).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>This study was supported in part by the Carlos III Health Institute (PI16/00950, PI18/00856); FEDER funds (‘A way to build Europe’) and by the Agency of University and Research Funding Management of the Catalan Government (2014SGR1672). M.A. was supported by the Secretariat for Universities and Research of the Ministry of Business and Knowledge of the Government of Catalonia. Grant co-funded by the European Social Fund (ESF) “ESF, Investing in your future” (2017 FI_B 00327). None of these funding sources participated in the preparation of the research article. We thank all the study participants from the Department of Psychiatry of Hospital Universitari de Bellvitge who collaborated to obtain the sample of this study.</p>
</ack>
<notes id="FPar1" notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par40">The authors declare that they have no conflict of interest.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruscio</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication</article-title>
<source/>Mol. Psychiatry
          <year>2010</year>
<volume>15</volume>
<fpage>53</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">18725912</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katerberg</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symptom dimensions in OCD: Item-level factor analysis and heritability estimates</article-title>
<source/>Behav. Genet
          <year>2010</year>
<volume>40</volume>
<fpage>505</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="pmid">20361247</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulze</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kathmann</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Getting it just right: a reevaluation of OCD symptom dimensions integrating traditional and Bayesian approaches</article-title>
<source/>J. Anxiety Disord.
          <year>2018</year>
<volume>56</volume>
<fpage>63</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">29739633</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Landeros-Weisenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rosario</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Pittenger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>Meta-analysis of the symptom structure of obsessive-compulsive disorder</article-title>
<source/>Am. J. Psychiatry
          <year>2008</year>
<volume>165</volume>
<fpage>1532</fpage>
<lpage>1542</lpage>
<pub-id pub-id-type="pmid">18923068</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mataix-Cols</surname>
<given-names>D</given-names>
</name>
<name>
<surname>do Rosario-Campos</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>JF</given-names>
</name>
</person-group>
<article-title>A multidimensional model of obsessive-compulsive disorder</article-title>
<source/>Am. J. Psychiatry
          <year>2005</year>
<volume>162</volume>
<fpage>228</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">15677583</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosario-Campos</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): An instrument for assessing obsessive-compulsive symptom dimensions</article-title>
<source/>Mol. Psychiatry
          <year>2006</year>
<volume>11</volume>
<fpage>495</fpage>
<lpage>504</lpage>
<pub-id pub-id-type="pmid">16432526</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brakoulias</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The familiality of specific symptoms of obsessive-compulsive disorder</article-title>
<source/>Psychiatry Res
          <year>2016</year>
<volume>239</volume>
<fpage>315</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="pmid">27058157</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy</article-title>
<source/>CNS Spectr.
          <year>2008</year>
<volume>13</volume>
<fpage>492</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">18567973</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasler</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study</article-title>
<source/>Biol. Psychiatry
          <year>2007</year>
<volume>61</volume>
<fpage>617</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="pmid">17027929</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cullen</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Factor analysis of the Yale-Brown obsessive compulsive scale in a family study of obsessive-compulsive disorder</article-title>
<source/>Depress. Anxiety
          <year>2007</year>
<volume>24</volume>
<fpage>130</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">16892417</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>AR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain structure and symptom dimension relationships in obsessive-compulsive disorder: A voxel-based morphometry study</article-title>
<source/>J. Affect Disord.
          <year>2008</year>
<volume>109</volume>
<fpage>117</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="pmid">18342953</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reess</surname>
<given-names>TJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between hippocampus volume and symptom profiles in obsessive–compulsive disorder</article-title>
<source/>NeuroImage Clin.
          <year>2018</year>
<volume>17</volume>
<fpage>474</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="pmid">29159060</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Biological heterogeneity of obsessive-compulsive disorder: a voxel-based morphometric study based on dimensional assessment</article-title>
<source/>Psychiatry Clin. Neurosci.
          <year>2015</year>
<volume>69</volume>
<fpage>411</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="pmid">25556718</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Via</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amygdala activation and symptom dimensions in obsessive-compulsive disorder</article-title>
<source/>Br. J. Psychiatry
          <year>2014</year>
<volume>204</volume>
<fpage>61</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">24262816</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder</article-title>
<source/>Biol. Psychiatry
          <year>2013</year>
<volume>73</volume>
<fpage>321</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">23200527</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domschke</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dannlowski</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Imaging genetics of anxiety disorders</article-title>
<source/>Neuroimage
          <year>2010</year>
<volume>53</volume>
<fpage>822</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="pmid">19944771</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexopoulos</surname>
<given-names>GS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression</article-title>
<source/>J. Affect Disord.
          <year>2010</year>
<volume>13</volume>
<fpage>1519</fpage>
<lpage>1523</lpage>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atmaca</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The association of myelin oligodendrocyte glycoprotein gene and white matter volume in obsessive-compulsive disorder</article-title>
<source/>J. Affect Disord.
          <year>2010</year>
<volume>124</volume>
<fpage>309</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="pmid">20452030</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2014</year>
<volume>264</volume>
<fpage>93</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="pmid">23880959</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tesli</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1C Risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<fpage>6</fpage>
<lpage>11.</lpage>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>M J</surname>
<given-names>TRJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response</article-title>
<source/>Asian J. Psychiatr.
          <year>2018</year>
<volume>38</volume>
<fpage>65</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">29079096</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lennertz</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option</article-title>
<source/>Eur. Neuropsychopharmacol.
          <year>2014</year>
<volume>24</volume>
<fpage>86</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">23928294</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo-Felippe</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Fontenelle</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Kohlrausch</surname>
<given-names>FB</given-names>
</name>
</person-group>
<article-title>Gene variations in PBX1, LMX1A and SLITRK1 are associated with obsessive-compulsive disorder and its clinical features</article-title>
<source/>J. Clin. Neurosci.
          <year>2019</year>
<volume>61</volume>
<fpage>180</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="pmid">30377043</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melo-Felippe</surname>
<given-names>FB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Catechol-O-methyltransferase gene polymorphisms in specific obsessive–compulsive disorder patients’ subgroups</article-title>
<source/>J. Mol. Neurosci.
          <year>2016</year>
<volume>58</volume>
<fpage>129</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="pmid">26687156</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder</article-title>
<source/>Psychoneuroendocrinology
          <year>2011</year>
<volume>36</volume>
<fpage>473</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="pmid">20850223</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kazuba</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism</article-title>
<source/>Am. J. Med Genet Part B Neuropsychiatr. Genet
          <year>2006</year>
<volume>141</volume>
<fpage>403</fpage>
<lpage>408</lpage>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reshma</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DRD4 gene and obsessive compulsive disorder: do symptom dimensions have specific genetic correlates?</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2013</year>
<volume>41</volume>
<fpage>18</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohlrausch</surname>
<given-names>FB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of GRIN2B gene polymorphism and obsessive compulsive disorder and symptom dimensions: a pilot study</article-title>
<source/>Psychiatry Res
          <year>2016</year>
<volume>243</volume>
<fpage>152</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">27394963</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CH</given-names>
</name>
</person-group>
<article-title>Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism</article-title>
<source/>Neuropsychobiology
          <year>2005</year>
<volume>52</volume>
<fpage>176</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="pmid">16220023</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavallini</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Di Bella</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Siliprandi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Malchiodi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bellodi</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism</article-title>
<source/>Am. J. Med Genet
          <year>2002</year>
<volume>114</volume>
<fpage>347</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">11920862</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<mixed-citation publication-type="other">Alonso, P. et al. Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene. In: <italic>mGenes, Brain Behav</italic>. 7, 778–785 (2008).</mixed-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinopoli</surname>
<given-names>VM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serotonin system genes and obsessive-compulsive trait dimensions in a population-based, pediatric sample: a genetic association study</article-title>
<source/>J. Child Psychol. Psychiatry Allied Discip.
          <year>2019</year>
<volume>12</volume>
<fpage>1289</fpage>
<lpage>1299</lpage>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katerberg</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of Obsessive-Compulsive Disorder (OCD)</article-title>
<source/>Am. J. Med Genet Part B Neuropsychiatr. Genet
          <year>2009</year>
<volume>150</volume>
<fpage>1050</fpage>
<lpage>1062</lpage>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Pittenger</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The genetics of obsessive-compulsive disorder</article-title>
<source/>Curr. Psychiatry Rev.
          <year>2010</year>
<volume>6</volume>
<fpage>91</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">23970845</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecrubier</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Refinement of diagnosis and disease classification in psychiatry</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2008</year>
<volume>258</volume>
<fpage>6</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">18344044</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">Waszczuk, M. A., Kotov, R., Ruggero, C., Gamez, W. &amp; Watson D. Supplemental material for hierarchical structure of emotional disorders: from individual symptoms to the spectrum. <italic>J. Abnorm. Psychol</italic>. 10.1037/abn0000264.supp (2017).</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<mixed-citation publication-type="other">American Psychiatric Association. <italic>DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders</italic>, 4th Ed. (American Psychiatric Press: Washington, DC, 1994).</mixed-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">First, M. B., Spitzer, R. L., Gibbon, M. &amp; Williams J. B. W. <italic>Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV)</italic> (1996).</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>WK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1989</year>
<volume>46</volume>
<fpage>1006</fpage>
<lpage>1011</lpage>
<pub-id pub-id-type="pmid">2684084</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
<source/>Am. J. Hum. Genet
          <year>2007</year>
<volume>81</volume>
<fpage>559</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<mixed-citation publication-type="other">Marees A. T. et al. A tutorial on conducting genome-wide association studies: quality control and statistical analysis. <italic>Int. J. Methods Psychiatr. Res.</italic>10.1002/mpr.1608 (2018)</mixed-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<mixed-citation publication-type="other">Aulchenko, Y. S., Ripke, S., Isaacs, A. &amp; van Duijn, C. M. GenABEL: An R library for genome-wide association analysis. <italic>Bioinformatics</italic>10.1093/bioinformatics/btm108 (2007).</mixed-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<mixed-citation publication-type="other">Pruim, R. et al. LocusZoom: regional visualization of genome-wide association scan results. <italic>Bioinformatics</italic>10.1093/bioinformatics/btq419 (2010).</mixed-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare-variant association testing for sequencing data with the sequence kernel association test</article-title>
<source/>Am. J. Hum. Genet
          <year>2011</year>
<volume>89</volume>
<fpage>82</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">21737059</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<mixed-citation publication-type="other">Voorman, A., Brody, J. &amp; Lumley T. SkatMeta: an R package for meta analyzing region-based tests of rare DNA variants (2013).</mixed-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources</article-title>
<source/>Nat. Protoc.
          <year>2009</year>
<volume>4</volume>
<fpage>44</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">19131956</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>
<source/>Nucleic Acids Res
          <year>2009</year>
<volume>37</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">19033363</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<mixed-citation publication-type="other">Kwiatkowski, S. et al. SETD3 protein is the actin-specific histidine N-methyltransferase. 10.7554/eLife.37921.001 (2018).</mixed-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<mixed-citation publication-type="other">Xiao, L., Yang, X. &amp; Loh, Y. P. Neurotrophic, gene regulation, and cognitive functions of carboxypeptidase E-neurotrophic factor-α1 and its variants. <italic>Front Neurosci</italic>10.3389/fnins.2019.00243 (2019).</mixed-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burguière</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mallet</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Graybiel</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Striatal circuits, habits, and implications for obsessive-compulsive disorder</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2015</year>
<volume>30</volume>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">25241072</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazari</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Narayanaswamy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Venkatasubramanian</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Neuroimaging findings in obsessive-compulsive disorder: a narrative review to elucidate neurobiological underpinnings</article-title>
<source/>Indian J. Psychiatry
          <year>2019</year>
<volume>61</volume>
<fpage>S9</fpage>
<lpage>S29</lpage>
<pub-id pub-id-type="pmid">30745673</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Giorgio</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Yoshioka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>St-Amand</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Feeding induced changes in the hypothalamic transcriptome</article-title>
<source/>Clin. Chim. Acta
          <year>2009</year>
<volume>406</volume>
<fpage>103</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="pmid">19523461</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scaini</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<fpage>e1111</fpage>
<pub-id pub-id-type="pmid">28463235</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagerberg</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics</article-title>
<source/>Mol. Cell Proteom.
          <year>2014</year>
<volume>13</volume>
<fpage>397</fpage>
<lpage>406</lpage>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cawley</surname>
<given-names>NX</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>SRK</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>YP</given-names>
</name>
</person-group>
<article-title>A novel single nucleotide T980C polymorphism in the human carboxypeptidase E gene results in loss of neuroprotective function</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>12.</lpage>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A human carboxypeptidase E/NF-α1 gene mutation in an Alzheimer’s disease patient leads to dementia and depression in mice</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e973</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">27922637</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cawley</surname>
<given-names>NX</given-names>
</name>
<name>
<surname>Loh</surname>
<given-names>YP</given-names>
</name>
</person-group>
<article-title>Carboxypeptidase E (NF-α1): a new trophic factor in neuroprotection</article-title>
<source/>Neurosci. Bull.
          <year>2014</year>
<volume>30</volume>
<fpage>692</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="pmid">24691800</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<mixed-citation publication-type="other">Grønli O., Kvamme J. M., Friborg O. &amp; Wynn R. Zinc deficiency is common in several psychiatric disorders. <italic>PLoS ONE</italic>10.1371/journal.pone.0082793 (2013)</mixed-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<mixed-citation publication-type="other">Portbury, S. D. &amp; Adlard P. A. Zinc signal in brain diseases. <italic>Int. J. Mol. Sci.</italic>10.3390/ijms18122506 (2017)</mixed-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McAllister</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Dyck</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2017</year>
<volume>80</volume>
<fpage>329</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="pmid">28624432</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<mixed-citation publication-type="other">Khan, K. et al. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia. <italic>Genet. Med</italic>. 10.1038/s41436-019-0523-0 (2019).</mixed-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Ambrosio</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Salvi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bogetto</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maina</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2012</year>
<volume>37</volume>
<fpage>136</fpage>
<lpage>140</lpage>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heckbert</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Depression in relation to long-term control of glycemia, blood pressure, and lipids in patients with diabetes</article-title>
<source/>J. Gen. Intern Med
          <year>2010</year>
<volume>25</volume>
<fpage>524</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="pmid">20182815</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>NK</given-names>
</name>
</person-group>
<article-title>Lipid Integration in neurodegeneration: an overview of alzheimer’s disease</article-title>
<source/>Mol. Neurobiol.
          <year>2014</year>
<volume>50</volume>
<fpage>168</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">24590317</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grela</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Application of fatty acid and lipid measurements in neuropsychiatry</article-title>
<source/>Clin. Chem. Lab. Med.
          <year>2016</year>
<volume>54</volume>
<fpage>197</fpage>
<lpage>206.</lpage>
<pub-id pub-id-type="pmid">26351933</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narayan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?</article-title>
<source/>Front Biosci.
          <year>2011</year>
<volume>16</volume>
<fpage>1797</fpage>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<mixed-citation publication-type="other">Mühle, C., Reichel, M., Gulbins, E. &amp; Kornhuber J. in <italic>Sphingolipids in Disease</italic> (eds Gulbins Erich &amp; Petrache I.) 431–456 (Springer Vienna: Vienna, 2013).</mixed-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides</article-title>
<source/>J. Proteome Res
          <year>2008</year>
<volume>7</volume>
<fpage>4266</fpage>
<lpage>4277</lpage>
<pub-id pub-id-type="pmid">18778095</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kornhuber</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High activity of acid sphingomyelinase in major depression</article-title>
<source/>J. Neural Transm.
          <year>2005</year>
<volume>112</volume>
<fpage>1583</fpage>
<lpage>1590</lpage>
<pub-id pub-id-type="pmid">16245071</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iguchi</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a Gα12/13 and Rho pathway</article-title>
<source/>J. Biol. Chem.
          <year>2008</year>
<volume>283</volume>
<fpage>14469</fpage>
<lpage>14478</lpage>
<pub-id pub-id-type="pmid">18378689</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zelek-Molik</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fear memory-induced alterations in the mRNA expression of G proteins in the mouse brain and the impact of immediate posttraining treatment with morphine</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2019</year>
<volume>93</volume>
<fpage>221</fpage>
<lpage>231</lpage>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grancharov</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Naydenova</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lozeva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Golovinsky</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title> Natural and synthetic inhibitors of UDP-glucuronosyltransferase</article-title>
<source/>Pharmacol. therapeut.
          <year>2001</year>
<volume>89</volume>
<fpage>171</fpage>
<lpage>186</lpage>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirashima</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity</article-title>
<source/>Mol. Pharm.
          <year>2016</year>
<volume>90</volume>
<fpage>265</fpage>
<lpage>274</lpage>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karabatsiakis</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolite profiling in posttraumatic stress disorder</article-title>
<source/>J. Mol. Psychiatry
          <year>2015</year>
<volume>3</volume>
<fpage>2</fpage>
<pub-id pub-id-type="pmid">25848535</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maes</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&amp;NS) pathways</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2011</year>
<volume>35</volume>
<fpage>784</fpage>
<lpage>794</lpage>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Melo</surname>
<given-names>LGP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog</article-title>
<source/>Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2017</year>
<volume>78</volume>
<fpage>34</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mellon</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hammamieh</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jett</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wolkowitz</surname>
<given-names>OM</given-names>
</name>
</person-group>
<article-title>Metabolism, metabolomics, and inflammation in posttraumatic stress disorder</article-title>
<source/>Biol. Psychiatry
          <year>2018</year>
<volume>83</volume>
<fpage>866</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="pmid">29628193</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perica</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Delaš</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Essential fatty acids and psychiatric disorders</article-title>
<source/>Nutr. Clin. Pract.
          <year>2011</year>
<volume>26</volume>
<fpage>409</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="pmid">21775637</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joëls</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Steroid hormones and excitability in the mammalian brain</article-title>
<source/>Front Neuroendocrinol.
          <year>1997</year>
<volume>18</volume>
<fpage>2</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="pmid">9000458</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gozzelino</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The pathophysiology of heme in the brain</article-title>
<source/>Curr. Alzheimer Res
          <year>2016</year>
<volume>13</volume>
<fpage>174</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">26391040</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonkovsky</surname>
<given-names>HL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Porphyrin and heme metabolism and the porphyrias</article-title>
<source/>Compr. Physiol.
          <year>2013</year>
<volume>3</volume>
<fpage>365</fpage>
<lpage>401.</lpage>
<pub-id pub-id-type="pmid">23720291</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidler</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Nikolovska</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Slc26 Family of anion transporters in the gastrointestinal tract: expression, function, regulation, and role in disease</article-title>
<source/>Compr. Physiol.
          <year>2019</year>
<volume>9</volume>
<fpage>839</fpage>
<lpage>872</lpage>
<pub-id pub-id-type="pmid">30873581</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malan-Muller</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiome and mental health: implications for anxiety- and trauma-related disorders</article-title>
<source/>Omi A J. Integr. Biol.
          <year>2018</year>
<volume>22</volume>
<fpage>90</fpage>
<lpage>107</lpage>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnet</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Bingmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Speckmann</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Wiemann</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Levetiracetam mediates subtle pH-shifts in adult human neocortical pyramidal cells via an inhibition of the bicarbonate-driven neuronal pH-regulation – Implications for excitability and plasticity modulation</article-title>
<source/>Brain Res
          <year>2019</year>
<volume>1710</volume>
<fpage>146</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="pmid">30590026</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal Microflora Studies in Late‐Onset Autism</article-title>
<source/>Clin. Infect. Dis.
          <year>2002</year>
<volume>35</volume>
<fpage>S6</fpage>
<lpage>S16.</lpage>
<pub-id pub-id-type="pmid">12173102</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mittal</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Ellman</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications</article-title>
<source/>Schizophr. Bull.
          <year>2008</year>
<volume>34</volume>
<fpage>1083</fpage>
<lpage>1094</lpage>
<pub-id pub-id-type="pmid">18635675</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goehler</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Opitz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lyte</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gaykema</surname>
<given-names>RPA</given-names>
</name>
</person-group>
<article-title>Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior</article-title>
<source/>Brain Behav. Immun.
          <year>2009</year>
<volume>22</volume>
<fpage>354</fpage>
<lpage>366</lpage>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bilbo</surname>
<given-names>SD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neonatal infection induces memory impairments following an immune challenge in adulthood</article-title>
<source/>Behav. Neurosci.
          <year>2005</year>
<volume>119</volume>
<fpage>293</fpage>
<lpage>301</lpage>
<pub-id pub-id-type="pmid">15727533</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<mixed-citation publication-type="other">Iervolino A. C. et al. Article Prevalence and Heritability of Compulsive Hoarding: A Twin Study. <ext-link ext-link-type="uri" xlink:href="http://www.vcu.edu/mx/">http://www.vcu.edu/mx/</ext-link> (2009)</mixed-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathews</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding</article-title>
<source/>Am. J. Med Genet Part B Neuropsychiatr. Genet
          <year>2007</year>
<volume>144</volume>
<fpage>174</fpage>
<lpage>182</lpage>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ament</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare variants in neuronal excitability genes influence risk for bipolar disorder</article-title>
<source/>Proc. Natl Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>3576</fpage>
<lpage>3581</lpage>
<pub-id pub-id-type="pmid">25730879</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<mixed-citation publication-type="other">Amin N. et al. A rare missense variant in RCL1 segregates with depression in extended families. <italic>Mol. Psychiatry</italic>10.1038/mp.2017.49 (2018)</mixed-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<mixed-citation publication-type="other">Singh T. et al. The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. <italic>Nat Genet</italic>. 10.1038/ng.3903 (2017).</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>